No abstract available
MeSH terms
-
Aged
-
Antibodies, Monoclonal, Murine-Derived / therapeutic use*
-
Antineoplastic Agents / therapeutic use*
-
Dose-Response Relationship, Drug
-
Drug Administration Schedule
-
Female
-
Follow-Up Studies
-
Humans
-
Psoriasis / diagnosis*
-
Psoriasis / drug therapy*
-
Rituximab
-
Severity of Illness Index
-
Time Factors
-
Treatment Outcome
Substances
-
Antibodies, Monoclonal, Murine-Derived
-
Antineoplastic Agents
-
Rituximab